[{"id":"b1c22dde-33a5-427e-8dc8-eaf11ab76624","acronym":"","url":"https://clinicaltrials.gov/study/NCT05076552","created_at":"2021-10-13T16:58:18.635Z","updated_at":"2024-07-02T16:35:01.730Z","phase":"Phase 1","brief_title":"A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer","source_id_and_acronym":"NCT05076552","lead_sponsor":"Tachyon Therapeutics, Inc.","biomarkers":" MSI","pipe":" | ","alterations":" MSI-H/dMMR","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e zavondemstat (TACH101)"],"overall_status":"Recruiting","enrollment":" Enrollment 70","initiation":"Initiation: 02/17/2023","start_date":" 02/17/2023","primary_txt":" Primary completion: 07/01/2025","primary_completion_date":" 07/01/2025","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2024-05-23"}]